Free tool
Mega cap stocks
We cover 22 companies in the mega cap size band. The median market value in the group is $263.59B. Across the group, the median move over the past trading day is +0.97%. 86% of the 22 with a 200-day average trade above it. Price change over the past year runs from −9.9% to +72.5% across the middle 80 percent of the group, with a median of +29.5%.
Other lists in this group
Table
22 of 300 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% | Oct 29, 2026 |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% | Oct 29, 2026 |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% | Oct 27, 2026 |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% | Oct 30, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% | Nov 4, 2026 |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.